As cell regeneration breakthroughs grow more and more promising, our responsibility to work accross disciplines and accross borders to assess the ever-growing needs of wound care patients becomes greater. That's our credo. That's RxGenesys Biotech.
A subsidiary of The RxGenesys Group, RxGenesys Biotech focuses on the implementation of microRNA and IPS Cells to stem cell therapies to create innovative wound healing products and solutions.
With the sole vision of improving the quality of wound healing and scar regeneration therapies currently in use, RxGenesys Biotech aims to present superior alternatives for milions of patients around the world.